Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 5/20 | 0.41 |
| ▸ | CNR1 | P21554 | 3/20 | 0.41 |
| ▸ | PPARG | P37231 | 2/20 | 0.41 |
| ▸ | PPARD | Q03181 | 2/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CETP | P11597 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL372689 | 0.92 | — | — | |
| SCHEMBL7744606 | 0.90 | TSHR (0.52) | CYP2D6CYP2C19TSHRALDH1A1MAPK1 | |
| SCHEMBL29770830 | 0.90 | TSHR (0.52) | CYP2D6CYP2C19TSHRALDH1A1MAPK1 | |
| Formic Acid SCHEMBL28269716 | 0.86 | TSHR (0.48) | CYP2D6CYP2C19TSHRALDH1A1MAPK1 | |
| Phosphonic Acid SCHEMBL28266598 | 0.84 | TSHR (0.46) | CYP2D6CYP2C19TSHRALDH1A1MAPK1 | |
| Acrylic Acid SCHEMBL20528130 | 0.84 | CYP2D6 (0.50) | CYP2D6CYP2C19TSHRALDH1A1MAPK1 | |
| Acrylamide SCHEMBL6553344 | 0.84 | TSHR (0.46) | CYP2D6CYP2C19TSHRALDH1A1MAPK1 | |
| Acrylamide SCHEMBL15635047 | 0.82 | TSHR (0.45) | CYP2D6CYP2C19TSHRALDH1A1MAPK1 | |
| SCHEMBL687556 | 0.82 | TSHR (0.45) | CYP2D6CYP2C19TSHRALDH1A1MAPK1 | |
| SCHEMBL28479385 | 0.81 | TSHR (0.43) | TSHRALDH1A1MAPK1TDP1ZDHHC20 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160030476-A1 | Compositions, Methods And Devices For Promoting Wound Healing And Reducing Infection | IASIS MOLECULAR SCIENCES (US) | 2016-02-04 | — | — | US | claimed |
| EP-2967076-A2 | COMPOSITIONS, METHODS AND DEVICES FOR PROMOTING WOUND HEALING AND REDUCING INFECTION | Iasis Molecular Sciences (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014153238-A9 | COMPOSITIONS, METHODS AND DEVICES FOR PROMOTING WOUND HEALING AND REDUCING INFECTION | IASIS MOLECULAR SCIENCES (US) | 2014-12-04 | — | — | WO | claimed |
| WO-2014153238-A2 | COMPOSITIONS, METHODS AND DEVICES FOR PROMOTING WOUND HEALING AND REDUCING INFECTION | IASIS MOLECULAR SCIENCES (US) | 2014-09-25 | — | — | WO | claimed |
| CN-112041276-A | Treatment method of circulating water of wet coating chamber | 栗田工业株式会社 | 2020-12-04 | — | — | CN | disclosed |
| US-20200039850-A1 | TREATMENT AGENT FOR WET-COATING-BOOTH CIRCULATING WATER | KURITA WATER INDUSTRIES LTD. (JP) | 2020-02-06 | — | — | US | disclosed |
| US-9159992-B2 | Negative electrode active material for lithium ion secondary battery and lithium ion secondary battery | ZEON CORPORATION (JP) | 2015-10-13 | — | — | US | disclosed |
| US-20130040206-A1 | ALL SOLID-STATE SECONDARY BATTERY AND A PRODUCTION METHOD OF AN ALL SOLID-STATE SECONDARY BATTERY | ZEON CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
| EP-2403040-A1 | NEGATIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM ION SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY | Zeon Corporation (JP) | 2012-01-04 | — | — | EP | disclosed |
| US-7964683-B2 | Biocompatible polymeric compound, biocompatible polymer and polymer particles | FUJIFILM CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-20100016534-A1 | BIOCOMPATIBLE POLYMERIC COMPOUND, BIOCOMPATIBLE POLYMER AND POLYMER PARTICLES | FUJIFILM CORPORATION (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-0793993-B1 | Process for treating waste water of flue gas desulfurization | KURITA WATER IND LTD (JP) | 2005-05-25 | — | — | EP | disclosed |
| CN-1114463-C | Process for treating waste water of flue gas desulfurization | KURITA WATER IND LTD (JP) | 2003-07-16 | — | — | CN | disclosed |
| US-5853598-A | Process for treating waste water of flue gas desulfurization | KURITA WATER INDUSTRIES LTD. (JP) | 1998-12-29 | — | — | US | disclosed |
| CN-1168296-A | Process for treating waste water of flue gas desulfurization | KURITA WATER IND LTD (JP) | 1997-12-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016534-A1 | BIOCOMPATIBLE POLYMERIC COMPOUND, BIOCOMPATIBLE POLYMER AND POLYMER PARTICLES | CD68, ARG1, PUF60 | CYP2D6 3825/4885CYP2C19 2246/4885TSHR 3373/4885 |
| US-20160030476-A1 | Compositions, Methods And Devices For Promoting Wound Healing And Reducing Infection | MMP8, IL1B, MMP1 | CYP2D6 2411/4885CYP2C19 1421/4885TSHR 3807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.